These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15199750)

  • 1. [Allogeneic peripheral blood stem cell transplantation for a hepatitis B virus carrier with Epstein-Barr virus associated with hemophagocytic syndrome].
    Sakai R; Maruta A; Yamazaki E; Kamijo A; Taguchi J; Hyo R; Tanaka M; Fujimaki K; Nagao T; Yoshiba M; Ishigatsubo Y
    Rinsho Ketsueki; 2004 May; 45(5):397-401. PubMed ID: 15199750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
    Uehara T; Nakaseko C; Hara S; Harima A; Ejiri M; Yokota A; Saito Y; Nishimura M
    Am J Hematol; 2004 Aug; 76(4):368-72. PubMed ID: 15282671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of a long-time survivor with chronic active Epstein-Barr virus infection.
    Takeoka Y; Nakao Y; Ueda M; Koh KR; Aoyama Y; Nakamae H; Yamamura R; Ohta K; Takubo T; Yamane T; Hino M; Tokura Y; Ishihara S; Oshima K; Kimura H; Imashuku S
    Eur J Haematol; 2004 Jan; 72(1):73-6. PubMed ID: 14962269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection.
    Fujii N; Takenaka K; Hiraki A; Maeda Y; Ikeda K; Shinagawa K; Ashiba A; Munemasa M; Sunami K; Hiramatsu Y; Ishimaru F; Niiya K; Yoshino T; Harada M
    Bone Marrow Transplant; 2000 Oct; 26(7):805-8. PubMed ID: 11042666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful umbilical cord blood transplantation from an unrelated donor for a patient with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Minegishi M; Ohashi Y; Kumaki S; Sasahara Y; Hayashi T; Asada H; Okuyama T; Hakozaki I; Sato T; Tsuchiya S
    Bone Marrow Transplant; 2001 Apr; 27(8):883-6. PubMed ID: 11477448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful report of reduced-intensity stem cell transplantation from unrelated umbilical cord blood in a girl with chronic active Epstein-Barr virus infection.
    Iguchi A; Kobayashi R; Sato TZ; Nakajima M; Kaneda M; Ariga T
    J Pediatr Hematol Oncol; 2006 Apr; 28(4):254-6. PubMed ID: 16679925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
    Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
    Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic active Epstein-Barr virus infection treated with reduced intensity stem cell transplantation].
    Sakata N; Sato E; Sawada A; Yasui M; Inoue M; Kawa K
    Rinsho Ketsueki; 2004 May; 45(5):393-6. PubMed ID: 15199749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epstein-Barr virus-associated hemophagocytic syndrome during mid-term pregnancy successfully treated with combined methylprednisolone and intravenous immunoglobulin].
    Mihara H; Kato Y; Tokura Y; Hattori Y; Sato A; Kobayashi H; Imamura A; Daimaru O; Miwa H; Nitta M
    Rinsho Ketsueki; 1999 Dec; 40(12):1258-64. PubMed ID: 10658479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N; Adachi A; Mori T; Kamata H; Nakahara J; Yokoyama K; Yamada T; Kizaki M; Sakamoto M; Ikeda Y; Okamoto S
    Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Imashuku S; Teramura T; Tauchi H; Ishida Y; Otoh Y; Sawada M; Tanaka H; Watanabe A; Tabata Y; Morimoto A; Hibi S; Henter JI
    Haematologica; 2004 Feb; 89(2):183-8. PubMed ID: 15003893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous resolution of hemophagocytic syndrome associated with acute parvovirus B19 infection and concomitant Epstein-Barr virus reactivation in an otherwise healthy adult.
    Larroche C; Scieux C; Honderlick P; Piette AM; Morinet F; Blétry O
    Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):739-42. PubMed ID: 12415473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
    J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus associated post-transplantation lymphoproliferative disorder with hemophagocytosis in a child with Wiskott-Aldrich syndrome.
    Wang IJ; Lu MY; Chiang BL; Lin WC; Lin DT; Lin KH
    Pediatr Blood Cancer; 2005 Sep; 45(3):340-3. PubMed ID: 15547918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature.
    George TI; Jeng M; Berquist W; Cherry AM; Link MP; Arber DA
    Pediatr Blood Cancer; 2005 Mar; 44(3):270-6. PubMed ID: 15468305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E; Cornelissen JJ
    Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virological and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome.
    Sato S; Kawashima H; Oshiro H; Hasegawa D; Kashiwagi Y; Takekuma K; Hoshika A
    J Clin Virol; 2004 Nov; 31(3):235-8. PubMed ID: 15465418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan.
    Imashuku S; Hibi S; Todo S; Sako M; Inoue M; Kawa K; Koike K; Iwai A; Tsuchiya S; Akiyama Y; Kotani T; Kawamura Y; Hirosawa M; Hasegawa D; Kosaka Y; Yamaguchi H; Ishii E; Kato K; Ishii M; Kigasawa H
    Bone Marrow Transplant; 1999 Mar; 23(6):569-72. PubMed ID: 10217187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.